Cardiac allograft vasculopathy after heart transplantation: risk factors and management.
about
Clinical utility of viral load in management of cytomegalovirus infection after solid organ transplantationConnective tissue growth factor promotes fibrosis downstream of TGFbeta and IL-6 in chronic cardiac allograft rejection.Coronary microvasculopathy in heart transplantation: Consequences and therapeutic implications.Acute cardiac allograft rejection by directly cytotoxic CD4 T cells: parallel requirements for Fas and perforin.Identification and classification of acute cardiac rejection by intragraft transcriptional profilingAnticardiac myosin immunity and chronic allograft vasculopathy in heart transplant recipients.Pregnancy outcomes in liver and cardiothoracic transplant recipients: a UK national cohort study.Cardiac allograft vasculopathy: a donor or recipient induced pathology?Association of CD14+ monocyte-derived progenitor cells with cardiac allograft vasculopathyFirst-year clinical outcomes in gender-mismatched heart transplant recipientsCardiac allograft vasculopathy: real or a normal morphologic variant?Recent advances in biomarker discovery in solid organ transplant by proteomics.An approach to endomyocardial biopsy interpretation.Influence of donor and recipient sex mismatch on heart transplant outcomes: analysis of the International Society for Heart and Lung Transplantation Registry.Cytomegalovirus infection and disease reduce 10-year cardiac allograft vasculopathy-free survival in heart transplant recipients.Human cytomegalovirus-specific T-cell immune reconstitution in preemptively treated heart transplant recipients identifies subjects at critical risk for infectionInhomogeneous myocardial stress perfusion in SPECT studies predicts future allograft dysfunction in heart transplant recipients.Inflammatory Ly-6C(hi) monocytes play an important role in the development of severe transplant arteriosclerosis in hyperlipidemic recipientsCardiac allograft vasculopathy: a reviewPretransplant diabetes, not donor age, predicts long-term outcomes in cardiac transplantation.Treatment of allograft vasculopathy in heart transplantation.Clinical outcomes in overweight heart transplant recipients.Review of nonimmunological causes for deteriorated graft function and graft loss after transplantation.The first year post-heart transplantation: use of immunosuppressive drugs and early complications.Viral infection induces de novo lesions of coronary allograft vasculopathy through a natural killer cell-dependent pathway.TGF-beta, IL-6, IL-17 and CTGF direct multiple pathologies of chronic cardiac allograft rejection.Drug eluting versus bare metal stents in cardiac allograft vasculopathy: a systematic review of literature.Protein and peptide biomarkers in organ transplantation.Metabolic syndrome in patients with hematological diseases.Interplay between immune responses to HLA and non-HLA self-antigens in allograft rejection.Combined usage of stem cells in end-stage heart failure therapies.Diagnosis and management of coronary allograft vasculopathy in children and adolescents.Calcineurin inhibitors cyclosporine A and tacrolimus induce vascular inflammation and endothelial activation through TLR4 signaling.Community-based weight management in long-term heart transplant recipients: a pilot study.Risk factors of cardiac allograft vasculopathy.The varying effects of obesity and morbid obesity on outcomes following cardiac transplantation.Controlled release hydrogen sulfide delivery system based on mesoporous silica nanoparticles protects graft endothelium from ischemia-reperfusion injury.Off-pump coronary artery bypass grafting for a left main lesion due to cardiac allograft vasculopathy in Japan: first report of a case.Complications related to the transplantation of thoracic organs: consensus definitions from the Multi-Societal Database Committee for Pediatric and Congenital Heart Disease.Cardiac allograft vasculopathy in pediatric heart transplant recipients.
P2860
Q26826856-F00FADD6-C423-4DD7-8A32-183A222FCB8BQ33811918-B73E7F60-7CD9-4B36-ABF7-609BD5856B10Q33891755-70324B11-C79E-449A-A17F-D23758994ED7Q34128024-EB989D3B-DC1C-4D45-A033-0E28DA9A2D7DQ35047164-665FB5E2-C10C-4541-9FAD-D516664D39B6Q35091339-DC3D95BE-6B5B-4ACA-9626-43A45F4BA871Q35106744-BB98CAB6-4694-4903-9BCB-994DBD0E1E2FQ35244151-87016E02-A863-44BC-A147-0EFE093C04D8Q35456617-687F0FD7-4372-40B6-99E7-415E2AF45248Q35638613-DCB00D12-CCE9-4BCF-9BAC-6C05FC3FCBEDQ35646016-3D8D1F46-2BE6-4BC1-AC81-73512A377F8DQ35764483-0AABEFC8-E0F7-4AAC-B14C-8DFD3DC4BF6DQ35769662-CFEBE79E-0060-4695-B25D-AD46EB68FF11Q35878133-CCABC535-90D8-4961-883F-525BC7B808EFQ35878194-E76BB562-28FC-44CC-BB42-6E19769BD7D4Q36023008-4A2F0D64-8B57-48AE-B21D-BD0C8F8B706DQ36123326-E7ADEB18-1C91-423D-891E-AF164628ADFFQ36177467-99B35224-7AA6-44AD-9B34-410622BF86A2Q36252106-0A92F58B-C6BC-4A47-B911-697119AAE85BQ36402649-2E475BEC-2DFF-4D37-8603-3BABE59500C0Q36655174-09890D30-C54F-4AA8-8B9B-6D7B5E5ABA95Q37072147-72D50143-8638-4AC7-B1A8-B22234EB8762Q37081669-14D21E55-2A9B-490B-9A5B-C12BABA57C66Q37089563-3F4C651F-0883-455E-AAB2-A4EEF93EAB6CQ37398139-C1896A36-0265-4D26-97C7-0C4300D9284FQ37773292-21F304CE-1FCA-41F1-8A54-C320C981CDCDQ37853958-12690AED-B2B1-4231-BB37-0214417A5079Q38021513-15339A9C-917F-46EB-A88F-FD09D115E71DQ38044776-5BAF1DAA-4B90-40CF-B0DA-20016A947410Q38123309-4B8388DF-F448-4690-A0F4-51AB5E83BB95Q38206163-5502CC62-4080-438F-ABC9-A40ED2048403Q38300629-48AADC73-8CE6-4D7A-99AB-19C98AD1C80AQ39688016-D5661B92-3E8C-4E09-B9DE-B67C16B2EA16Q40128297-A2464AC1-3627-4B50-B1EC-3C9DD5EDD920Q40800486-05009CC7-D592-4098-99AA-1CD51C3E5E4FQ40924194-88057A3A-3262-4E67-A12E-9965939C3CB8Q42407985-297F9AAB-69FD-4CB7-B1FB-611F1527ACE6Q45222416-23B1C360-63FE-4B07-B126-F93C1A302209Q46384278-FACA18E2-F82E-49F7-97F1-23B7E0278DA8Q46915304-0E52959D-05F5-45DA-BD4C-4AE7FD3A1F78
P2860
Cardiac allograft vasculopathy after heart transplantation: risk factors and management.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Cardiac allograft vasculopathy after heart transplantation: risk factors and management.
@ast
Cardiac allograft vasculopathy after heart transplantation: risk factors and management.
@en
type
label
Cardiac allograft vasculopathy after heart transplantation: risk factors and management.
@ast
Cardiac allograft vasculopathy after heart transplantation: risk factors and management.
@en
prefLabel
Cardiac allograft vasculopathy after heart transplantation: risk factors and management.
@ast
Cardiac allograft vasculopathy after heart transplantation: risk factors and management.
@en
P1476
Cardiac allograft vasculopathy after heart transplantation: risk factors and management.
@en
P304
P356
10.1016/J.HEALUN.2004.03.009
P433
P577
2004-05-01T00:00:00Z